SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-065428
Filing Date
2018-11-01
Accepted
2018-11-01 16:20:00
Documents
43
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19022_110q.htm 10-Q 997345
2 EX-31.1 a18-19022_1ex31d1.htm EX-31.1 11056
3 EX-31.2 a18-19022_1ex31d2.htm EX-31.2 11118
4 EX-32.1 a18-19022_1ex32d1.htm EX-32.1 7316
  Complete submission text file 0001104659-18-065428.txt   3957463

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT espr-20180930.xml EX-101.INS 903125
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20180930.xsd EX-101.SCH 24085
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20180930_cal.xml EX-101.CAL 32198
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20180930_lab.xml EX-101.LAB 283756
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20180930_pre.xml EX-101.PRE 177669
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20180930_def.xml EX-101.DEF 90998
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 181154016
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1